NM_032122.5:c.489-8dupT

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The NM_032122.5(DTNBP1):​c.489-8dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.206 in 1,236,686 control chromosomes in the GnomAD database, including 2,611 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.18 ( 2285 hom., cov: 28)
Exomes 𝑓: 0.21 ( 326 hom. )

Consequence

DTNBP1
NM_032122.5 splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.127

Publications

2 publications found
Variant links:
Genes affected
DTNBP1 (HGNC:17328): (dystrobrevin binding protein 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. A similar protein in mouse is a component of a protein complex termed biogenesis of lysosome-related organelles complex 1 (BLOC-1), and binds to alpha- and beta-dystrobrevins, which are components of the dystrophin-associated protein complex (DPC). Mutations in this gene are associated with Hermansky-Pudlak syndrome type 7. This gene may also be associated with schizophrenia. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
DTNBP1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 6-15593088-G-GA is Benign according to our data. Variant chr6-15593088-G-GA is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 355969.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.326 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DTNBP1NM_032122.5 linkc.489-8dupT splice_region_variant, intron_variant Intron 6 of 9 ENST00000344537.10 NP_115498.2 Q96EV8-1A0A0S2Z5U8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DTNBP1ENST00000344537.10 linkc.489-8_489-7insT splice_region_variant, intron_variant Intron 6 of 9 1 NM_032122.5 ENSP00000341680.6 Q96EV8-1

Frequencies

GnomAD3 genomes
AF:
0.178
AC:
24111
AN:
135696
Hom.:
2288
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.250
Gnomad AMI
AF:
0.0721
Gnomad AMR
AF:
0.177
Gnomad ASJ
AF:
0.140
Gnomad EAS
AF:
0.340
Gnomad SAS
AF:
0.248
Gnomad FIN
AF:
0.0776
Gnomad MID
AF:
0.154
Gnomad NFE
AF:
0.132
Gnomad OTH
AF:
0.184
GnomAD2 exomes
AF:
0.227
AC:
22320
AN:
98290
AF XY:
0.226
show subpopulations
Gnomad AFR exome
AF:
0.274
Gnomad AMR exome
AF:
0.224
Gnomad ASJ exome
AF:
0.228
Gnomad EAS exome
AF:
0.316
Gnomad FIN exome
AF:
0.170
Gnomad NFE exome
AF:
0.199
Gnomad OTH exome
AF:
0.225
GnomAD4 exome
AF:
0.210
AC:
230914
AN:
1100954
Hom.:
326
Cov.:
0
AF XY:
0.209
AC XY:
114865
AN XY:
548704
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.276
AC:
6862
AN:
24872
American (AMR)
AF:
0.181
AC:
4973
AN:
27546
Ashkenazi Jewish (ASJ)
AF:
0.187
AC:
3801
AN:
20356
East Asian (EAS)
AF:
0.286
AC:
9526
AN:
33298
South Asian (SAS)
AF:
0.250
AC:
16068
AN:
64290
European-Finnish (FIN)
AF:
0.127
AC:
5365
AN:
42202
Middle Eastern (MID)
AF:
0.240
AC:
1094
AN:
4564
European-Non Finnish (NFE)
AF:
0.207
AC:
173180
AN:
837600
Other (OTH)
AF:
0.217
AC:
10045
AN:
46226
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.356
Heterozygous variant carriers
0
10858
21715
32573
43430
54288
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7066
14132
21198
28264
35330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.178
AC:
24117
AN:
135732
Hom.:
2285
Cov.:
28
AF XY:
0.179
AC XY:
11698
AN XY:
65400
show subpopulations
African (AFR)
AF:
0.250
AC:
9367
AN:
37448
American (AMR)
AF:
0.177
AC:
2399
AN:
13564
Ashkenazi Jewish (ASJ)
AF:
0.140
AC:
453
AN:
3238
East Asian (EAS)
AF:
0.340
AC:
1644
AN:
4834
South Asian (SAS)
AF:
0.249
AC:
1068
AN:
4294
European-Finnish (FIN)
AF:
0.0776
AC:
569
AN:
7332
Middle Eastern (MID)
AF:
0.156
AC:
42
AN:
270
European-Non Finnish (NFE)
AF:
0.132
AC:
8162
AN:
62032
Other (OTH)
AF:
0.188
AC:
352
AN:
1874
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
905
1810
2716
3621
4526
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
266
532
798
1064
1330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0694
Hom.:
18

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199770715; hg19: chr6-15593319; COSMIC: COSV59036741; API